Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Travere Therapeutics, Inc. | 12,000 | reported | 19 May 2026 | tx 10+98,000 |
| Natera, Inc. | 5,475 | reported | 24 Apr 2026 | tx 10+17,305 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 May 2026 | GRANT_AWARD | Travere Therapeutics, Inc. | 4,000 | 0.00 USD | |
| 19 May 2026 | GRANT_AWARD | Travere Therapeutics, Inc. | 12,000 | 0.00 USD | deriv |
| 24 Apr 2026 | GRANT_AWARD | Natera, Inc. | 86 | — | |
| 30 Jan 2026 | GRANT_AWARD | Natera, Inc. | 73 | — | |
| 31 Oct 2025 | GRANT_AWARD | Natera, Inc. | 97 | — | |
| 25 Jul 2025 | GRANT_AWARD | Natera, Inc. | 112 | — | |
| 27 Jun 2025 | GRANT_AWARD | Natera, Inc. | 2,143 | — | |
| 15 May 2025 | GRANT_AWARD | Travere Therapeutics, Inc. | 6,500 | 0.00 USD | |
| 15 May 2025 | GRANT_AWARD | Travere Therapeutics, Inc. | 19,500 | 0.00 USD | deriv |
| 28 Jun 2024 | GRANT_AWARD | Natera, Inc. | 2,964 | — | |
| 08 May 2024 | GRANT_AWARD | Travere Therapeutics, Inc. | 6,500 | 0.00 USD | |
| 08 May 2024 | GRANT_AWARD | Travere Therapeutics, Inc. | 19,500 | 0.00 USD | deriv |
| 27 Oct 2023 | GRANT_AWARD | Natera, Inc. | 515 | 25.03 USD | deriv |
| 28 Jul 2023 | GRANT_AWARD | Natera, Inc. | 428 | 29.68 USD | deriv |
| 17 May 2023 | GRANT_AWARD | Travere Therapeutics, Inc. | 4,500 | 0.00 USD | |
| 17 May 2023 | GRANT_AWARD | Travere Therapeutics, Inc. | 13,500 | 0.00 USD | deriv |
| 14 Apr 2023 | GRANT_AWARD | Natera, Inc. | 120 | 32.88 USD | deriv |
| 24 Mar 2023 | GRANT_AWARD | Natera, Inc. | 10,767 | 0.00 USD | deriv |
| 11 May 2022 | GRANT_AWARD | Travere Therapeutics, Inc. | 3,000 | 0.00 USD | |
| 11 May 2022 | GRANT_AWARD | Travere Therapeutics, Inc. | 9,000 | 0.00 USD | deriv |